Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria announced the acquisition of e-vapor company NJOY yesterday. Altria simultaneously exited its failed investment in Juul Labs.

Altria: Going On The Offensive

Altria is entering the vaping market with NJOY. The acquisition poses little risk to the dividend.

What Altria's Latest $2.75 Billion Purchase Means for Shareholders

Altria Group recently announced it is buying NJOY Holdings, Inc. (NJOY) for approximately $2.75 billion in cash payable at closing. These are the details.

Why Altria Is Buying NJOY For About $2.75 Billion In Cash (MO)

MO's repeated capital allocation blunders have destroyed billions of dollars in shareholder value. We look at the latest quarterly results as well as Altria's latest deals.

Altria Continues To Destroy Shareholder Value

Altria reported solid results for fiscal 2022 with moderate top line growth and a solid outlook for fiscal 2023. MO stock is still attractive for its 8% dividend yield and seems to be trading at least for its intrinsic value.

Altria: Attractive Dividend Payer, But Declining Business

Marlboro maker Altria Group Inc said that it would buy vaping pioneer NJOY Holdings Inc for at least $2.75 billion, after closing the chapter on its ill-fated investment in e-cigarette maker Juul Labs Inc. The deal will give Altria full global ownership of NJOY's e-vapor product portfolio, including NJOY ACE, the only pod-based e-vapor product with market authorizations from the US Food and Drug Administration (FDA).

Altria to buy e-cigarette startup NJOY for $2.8 billion after Juul exit

Altria is betting that NJOY will prove to be an easier way to tap the market since six of the company's products have received full approval from the Food and Drug Administration.

Altria buys NJOY for $2.75B in new bet on e-cigarette market

Past failures should not be the reason to stop trying. Altria Group, Inc.'s outright ownership makes NJOY acquisition different from Juul stake.

NJOY Altria: This Time May Be Different

Altria's deal to buy NJOY comes after the Marlboro maker exited its position in Juul Labs.

Marlboro maker Altria agrees to buy e-cigarette startup NJOY for nearly $2.8 billion

Altria Group Inc. said Monday it would buy e-vapor company NJOY Holdings Inc. for $2.75 billion in cash, its second deal in recent days in the smokeless-tobacco space.

Altria deepens push into vape biz with two deals

Altria agrees to pay at least $2.75 billion for NJOY as it switches vaping strategy.

Marlboro Maker Ditches Juul and Buys NJOY

NJOY is one of the few e-cigarette makers whose products have clearance from federal regulators.

Altria to Buy Vaping Company NJOY for $2.75 Billion

Altria Group Inc. MO, +0.15% said Monday it has agreed to acquire NJOY Holdings Inc. for about $2.75 billion cash to be paid at closing. The tobacco giant said the deal will give it control of all of NJOY's e-vapor product portfolio and will include $500 million of additional payments based on reaching certain regulatory milestones.

Altria to acquire e-vapor play NJOY Holdings for $2.75 billion in cash to be paid at closing

Altria Group Inc said on Monday it would buy e-cigarette startup NJOY Holdings Inc for about $2.75 billion in cash, in fresh bets by the Marlboro maker on the fast-growing market after losing billions through its investment in Juul.

Altria to buy e-cigarette startup NJOY for $2.8 bln after Juul exit

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ACQUIRE--Altria to Host Webcast to Discuss Altria's Definitive Agreement to Acquire NJOY Holdings, Inc.

Altria to Host Webcast to Discuss Altria's Definitive Agreement to Acquire NJOY Holdings, Inc.

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ACQUIRE--Altria Announces Definitive Agreement to Acquire NJOY Holdings, Inc.

Altria Announces Definitive Agreement to Acquire NJOY Holdings, Inc.

Tobacco giant Altria MO, +0.15% on Friday said it had exchanged its minority stake in embattled e-cigarette maker Juul for “a non-exclusive, irrevocable global license to certain of JUUL's heated tobacco intellectual property.” Altria Chief Executive Billy Gifford said in a statement that “We believe exchanging our Juul ownership for intellectual property rights is the appropriate path forward for our business.

Altria exchanges stake in Juul for heated-tobacco intellectual property

Altria Exchanges Minority Stake in JUUL Labs for Heated Tobacco Intellectual Property Rights

Danaher

Enbridge

Extra Space Storage

Intuit

Johnson & Johnson

Lockheed Martin

Old Dominion Freight Line

PepsiCo

Schwab US Dividend Equity ETF

SPDR S&P 500 ETF Trust

Thermo Fisher Scientific

Union Pacific

Vanguard Total Stock Market ETF

Verizon

We start with a discussion of diversification theories based on the findings of a scientific article called "The Dividend Puzzle". While inexperienced investors should stick to ETFs, there's a clear case to be made for the behavioral approach, which is based on a mix of different dividend strategies.

The Dividend Pyramid: Potentially Beat The Market With This 12-Stock Portfolio

British American Tobacco

Philip Morris

Altria Group, Inc., British American Tobacco p.l.c., and Philip Morris International Inc. are three of the best-performing high-yield blue-chips in history. Today, Altria is struggling with its transition to a smoke-free future, but likely has sufficient time to make the leap.

Altria Vs. British American Vs. Philip Morris: Battle Of The High-Yield Aristocrats

Altria has fallen behind the broader market, and now it's considering another strategic move that might lead investors to worry.

Altria Is Down 18% From Its 52-Week High. Time to Buy?

Altria is probably the best-performing stock ever with a huge following. But the best days are over, and now you should not expect annual returns in the twenties.

Altria: Blueprint For Fabulous Returns

Newell Brands

Pioneer Natural Resources

V.F.

A high dividend yield can be an attractive feature, as it's a way of gauging a stock's dividend payout relative to its price. Some of the highest yields can be found in oil-and-gas master limited partnerships and tanker companies, but you can also get high yields from many other sectors and industries.

3 High-Yield Dividend Stocks That Are Probably Not On Your Radar

Njoy Holdings' acquisition would not add much and appears unlikely in my view. Cigarette and oral-tobacco unit volume and selling prices are Altria Group's most important drivers for operating success.

Altria: Stock Is Cheap But Risks Remain

RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (NYSE: MO) today announced that our Board of Directors declared a regular quarterly dividend of $0.94 per share, payable on April 28, 2023 to shareholders of record as of March 24, 2023. The ex-dividend date is March 23, 2023.

News for Altria Stock (MO)